- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4164 - 1,3-Diazoles
Patent holdings for IPC class A61K 31/4164
Total number of patents in this class: 2546
10-year publication summary
|
163
|
152
|
194
|
187
|
181
|
188
|
184
|
120
|
148
|
151
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20289 |
28 |
| Allergan, Inc. | 2314 |
27 |
| Evofem Biosciences, Inc. | 48 |
20 |
| Centre National de La Recherche Scientifique | 10693 |
17 |
| Bristol-myers Squibb Company | 4820 |
15 |
| The Cleveland Clinic Foundation | 1572 |
15 |
| F. Hoffmann-La Roche AG | 7933 |
14 |
| FUJIFILM Corporation | 29817 |
14 |
| Cedars-Sinai Medical Center | 1176 |
14 |
| Journey Medical Corporation | 94 |
14 |
| University of Tennessee Research Foundation | 754 |
14 |
| Novartis AG | 10623 |
13 |
| The Regents of the University of Michigan | 4780 |
12 |
| Astellas Pharma Inc. | 1057 |
12 |
| Enanta Pharmaceuticals, Inc. | 434 |
12 |
| Pharnext | 87 |
12 |
| Abbvie Inc. | 1815 |
11 |
| Antecip Bioventures II LLC | 347 |
10 |
| Celltrion, Inc. | 361 |
10 |
| Galderma Research & Development | 389 |
10 |
| Other owners | 2252 |